Aadi Bioscience Inc.

NASDAQ: AADI · Real-Time Price · USD
2.05
-0.05 (-2.38%)
At close: Mar 18, 2025, 3:59 PM

Aadi Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
28.67M 62.89M 39.02M 148.99M
Short-Term Investments
18.57M 45.96M 133.54M n/a
Long-Term Investments
n/a n/a 64K n/a
Other Long-Term Assets
1.4M 1.87M 2.11M 2.21M
Receivables
5.9M 5.49M 1.86M n/a
Inventory
5.31M 6.43M 1.86M n/a
Other Current Assets
2.84M 3.83M 3.75M 2.28M
Total Current Assets
61.29M 124.59M 180.03M 151.27M
Property-Plant & Equipment
7.63M 5.97M 2.03M 614K
Goodwill & Intangibles
n/a n/a n/a 3.81M
Total Long-Term Assets
9.03M 7.84M 4.21M 6.64M
Total Assets
70.32M 132.42M 184.24M 157.91M
Account Payables
2.16M 5.9M 3.52M 6.44M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 394K n/a
Other Current Liabilities
64K 5.76M 7.77M n/a
Total Current Liabilities
17.07M 26.39M 18.84M 15.27M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
202K n/a 5.76M 5.76M
Total Long-Term Liabilities
767K 833K 7.02M 6.23M
Total Liabilities
17.84M 27.23M 25.86M 21.5M
Total Debt
833K 1.27M 1.66M 605K
Common Stock
2K 2K 2K 2K
Retained Earnings
-332.65M -268.96M -203.2M -142.69M
Comprehensive Income
16K 27K -115K n/a
Shareholders Equity
52.48M 105.19M 158.38M 136.41M
Total Investments
18.57M 45.96M 133.54M n/a